Spots Global Cancer Trial Database for bi 811283 (d 1 and 15)
Every month we try and update this database with for bi 811283 (d 1 and 15) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment | NCT00632749 | Leukemia, Myelo... | BI 811283 (d 1 ... Cytarabine BI 811283 (d1) Cytarabine | 18 Years - | Boehringer Ingelheim | |
BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment | NCT00632749 | Leukemia, Myelo... | BI 811283 (d 1 ... Cytarabine BI 811283 (d1) Cytarabine | 18 Years - | Boehringer Ingelheim |